🇺🇸 US

BIIB revenue, net income and debt history (Biogen Inc.)

Quick answer

Biogen Inc. (BIIB) reported revenue of $9.89B and net income of $1.29B for the fiscal year ended 2025-12-31, up 2.2% from $9.68B the year before, per its 10-K filed with the SEC on 2026-02-06. Long-term debt stood at $6.29B.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Fiscal yearRevenueNet incomeLong-term debt
2025 (FY ending 2025-12-31)$9.89B$1.29B$6.29B
2024 (FY ending 2024-12-31)$9.68B$1.63B$6.30B
2023 (FY ending 2023-12-31)$9.84B$1.16B$6.94B
2022 (FY ending 2022-12-31)$10.17B$3.05B$6.28B
2021 (FY ending 2021-12-31)$10.98B$1.56B$6.27B
2020 (FY ending 2020-12-31)$13.44B$4.00B$7.43B
2019 (FY ending 2019-12-31)$14.38B$5.89B$4.46B
2018 (FY ending 2018-12-31)$13.45B$4.43B$5.94B
2017 (FY ending 2017-12-31)$12.27B$2.54B$5.93B
2016 (FY ending 2016-12-31)$11.45B$3.70B$6.51B

Related

Last updated 2026-10-16. Data only, not financial or tax advice.